DYRK3
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 3
Gene Information Card
| Symbol | DYRK3 |
|---|---|
| Full Name | Dual Specificity Tyrosine Phosphorylation Regulated Kinase 3 |
| Gene Type | Protein coding |
| Chromosomal Location | 1q32.1 |
| NCBI Gene ID | 8444 ncbi.nlm.nih.gov/gene/8444 |
| Ensembl ID | ENSG00000143479 |
| UniProt ID | O43781 |
| OMIM ID | 603497 |
| HGNC ID | 3094 |
| Aliases | DYRK5, REDK, hYAK3-2 |
Description
DYRK3 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 3) is a member of the DYRK family of protein kinases. It encodes a nuclear protein that functions as a dual-specificity kinase, capable of autophosphorylation on tyrosine residues and phosphorylation of serine/threonine substrates. DYRK3 plays critical roles in cell cycle regulation, hematopoiesis, and stress granule dynamics. It is involved in the regulation of the G1/S cell cycle transition and is essential for erythropoiesis and megakaryopoiesis. DYRK3 also acts as a molecular switch controlling the dissolution of stress granules during mitosis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Acute Myeloid Leukemia (AML) | DYRK3 is recurrently mutated in AML; loss-of-function mutations may impair hematopoietic differentiation. | COSMIC, ClinVar |
| Myelodysplastic Syndromes (MDS) | Somatic mutations in DYRK3 have been identified in MDS patients, potentially contributing to dysplastic hematopoiesis. | COSMIC |
| Colorectal Cancer | DYRK3 overexpression has been reported in colorectal cancer; may promote cell proliferation. | NCBI Gene, PubMed |
| Hepatocellular Carcinoma | Altered DYRK3 expression is associated with poor prognosis in liver cancer. | PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Bone Marrow | 12.5 | Medium |
| Spleen | 8.3 | Medium |
| Testis | 6.1 | Low |
| Brain | 4.2 | Low |
| Liver | 3.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| K562 (leukemia) | 15.2 | High expression |
| HEK293 (embryonic kidney) | 7.8 | Moderate expression |
| HepG2 (liver cancer) | 5.4 | Low expression |
| HeLa (cervical cancer) | 4.1 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1015C>T (p.Arg339Trp) | Missense | 0.02% (COSMIC) | Unknown functional effect; located in kinase domain |
| c.1246G>A (p.Glu416Lys) | Missense | 0.01% (COSMIC) | Potential loss of kinase activity |
| c.1489_1490insA (p.Thr497Asnfs*12) | Frameshift | 0.005% (COSMIC) | Predicted loss of function |
Mutation functional classification
Loss of Function (LOF)
Frameshift and nonsense mutations in DYRK3 are predicted to result in loss of kinase activity and impaired cellular function.
Gain of Function (GOF)
No well-characterized gain-of-function mutations have been reported for DYRK3.
Dominant Negative (DN)
No dominant-negative mutations have been described for DYRK3.
View complete mutation data:
Gene Ontology (GO)
Pathways
• DYRK family signaling
• Cell cycle (G1/S transition)
• Stress granule dynamics
Protein Summary
DYRK3 is a 588-amino acid dual-specificity kinase that contains a conserved DYRK homology domain and a nuclear localization signal. It undergoes autophosphorylation on tyrosine residues for activation and subsequently phosphorylates serine/threonine substrates. DYRK3 is predominantly nuclear and regulates cell cycle progression, particularly the G1/S transition. It is essential for proper hematopoiesis, including erythroid and megakaryocytic differentiation. Additionally, DYRK3 controls the disassembly of stress granules during mitosis, linking cellular stress responses to cell cycle progression. Dysregulation of DYRK3 is implicated in hematologic malignancies and solid tumors.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DYRK3 Knockout HEK293 Cell Line | EDJ-KQ2289 | Human | 8444 | Details Get a Quote |
| DYRK3 Knockout HCT 116 Cell Line | EDJ-KQ21317 | Human | 8444 | Details Get a Quote |
| DYRK3 Knockout A-549 Cell Line | EDJ-KQ22645 | Human | 8444 | Details Get a Quote |
| DYRK3 Knockout HeLa Cell Line | EDJ-KQ22646 | Human | 8444 | Details Get a Quote |